Correlation Between Vanda Pharmaceuticals and Lipocine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vanda Pharmaceuticals and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vanda Pharmaceuticals and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vanda Pharmaceuticals and Lipocine, you can compare the effects of market volatilities on Vanda Pharmaceuticals and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vanda Pharmaceuticals with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vanda Pharmaceuticals and Lipocine.

Diversification Opportunities for Vanda Pharmaceuticals and Lipocine

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Vanda and Lipocine is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Vanda Pharmaceuticals and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and Vanda Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vanda Pharmaceuticals are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of Vanda Pharmaceuticals i.e., Vanda Pharmaceuticals and Lipocine go up and down completely randomly.

Pair Corralation between Vanda Pharmaceuticals and Lipocine

Given the investment horizon of 90 days Vanda Pharmaceuticals is expected to under-perform the Lipocine. But the stock apears to be less risky and, when comparing its historical volatility, Vanda Pharmaceuticals is 1.38 times less risky than Lipocine. The stock trades about -0.02 of its potential returns per unit of risk. The Lipocine is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  765.00  in Lipocine on August 23, 2024 and sell it today you would lose (265.00) from holding Lipocine or give up 34.64% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Vanda Pharmaceuticals  vs.  Lipocine

 Performance 
       Timeline  
Vanda Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vanda Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Lipocine 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lipocine are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Lipocine displayed solid returns over the last few months and may actually be approaching a breakup point.

Vanda Pharmaceuticals and Lipocine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vanda Pharmaceuticals and Lipocine

The main advantage of trading using opposite Vanda Pharmaceuticals and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vanda Pharmaceuticals position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.
The idea behind Vanda Pharmaceuticals and Lipocine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings